NEW HAVEN, Conn., Nov. 4 /PRNewswire-FirstCall/ -- VION PHARMACEUTICALS, INC. (OTC Bulletin Board: VION) announced updated call information for its conference call on Thursday, November 6, 2008 to discuss its 2008 third quarter financial results.
The call will begin at 8:30 a.m. Eastern Time.
To participate in the conference call, please dial (866) 831-6270 in the U.S., ((617) 213-8858 for international callers), at least 15 minutes before the start of the call. When prompted for a pass code, please enter 85439318.
An audio webcast of the call will be accessible at http://www.vionpharm.com. Those who wish to listen to the conference call on the Web should visit the Investor Relations section of the Company's website at least 15 minutes prior to the event broadcast, and follow the instructions provided to assure that the necessary audio applications are downloaded and installed. These programs can be obtained at no charge to the user.
A replay of the call will be available two hours after the completion of the call at (888) 286-8010 in the U.S., ((617) 801-6888 for international callers), pass code 37383579. The replay will be available through Thursday, November 20, 2008.
About Vion
Vion Pharmaceuticals, Inc. is committed to extending the lives and
improving the quality of life of cancer patients worldwide by developing
and commercializing innovative cancer therapeutics. Vion has two agents in
clinical trials. Laromustine (Cloretazine(R), VNP40101M), a unique
alkylating agent, is being evaluated in a Phase II pivotal trial as a
single agent in elderly patients with previously untreated de novo
poor-risk acute myelogenous leukemia. Clinical trials of laromustine
(Cloretazine(R), VNP40101M) with cytarabine in elderly patients with acute
myelogenous leukemia, with temozolomide in brain tumors, and with stem cell
transplantation in advanced hematologic malignancies, are
'/>"/>
| SOURCE Vion Pharmaceuticals, Inc. Copyright©2008 PR Newswire. All rights reserved |